// App-Quantinova.ai

DXT34 : Revealing the Immune Cell Subtype Reconstitution Profile in Cladribine Treated Patients at the 96 Week Timepoint (CLARITY) Using Deconvolution Algorithms

Researchers

Presenter

  • Irina Kalatskaya

Principal Investigators

  • Gavin Giovannoni

  • Thomas P. Leist

  • Per Soelberg-Sorensen

  • Ursula Boschert

  • Julie DeMartino

  • Alex Rolfe

Medical Centers

  • Danish MS Center, University of Copenhagen

  • Blizard Institute of Cell and Molecular Science Queen Mary University of London

  • Jefferson University Hospital,

Locations

  • Denmark

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Cladribine

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved